Virus inactivation in the 1990s - And into the 21st century: Part 2, red blood cells and platelets

BioPharm

Volumn 15, Issue 8, 2002, Pages 42-49

  Sofer, Gail ^a  

^a BioReliance   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; MEROCYANINE; PHENOTHIAZINE DERIVATIVE; PHTHALOCYANINE; PORPHYRIN DERIVATIVE; PSORALEN;

BLOOD TRANSFUSION; COVALENT BOND; ERYTHROCYTE MEMBRANE; HUMAN; HUMAN CELL; PHOTOACTIVATION; PHOTODYNAMICS; REVIEW; SAFETY; THROMBOCYTE MEMBRANE; VIRUS INACTIVATION; VIRUS INFECTION;

EID: 0036340119     PISSN: 10408304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Virus inactivation in the 1990s - And into the 21st century: Skin, bone, and cells
2. Inactivation of viruses found with cellular components
3. New technologies for viral inactivation
4. Preservation of red cell properties after virucidal phototreatment with dimethylmethylene blue
5. Comparison of methylene blue and methylene violet for photoinactivation of intracellular and extracellular virus in red cell suspensions
6. Differential sensitivities of viruses in red cell suspensions to methylene blue photosensitization
7. Duck hepatitis B photoinactivation by dimethylmethylene blue in RBC suspensions
8. Biodistribution and virus inactivation efficacy of a silicon phthalocyanine in RBC concentrates as a function of delivery vehicle
9. Sulfophthalocyanines for photodynamic inactivation of viruses in blood products: Effect of structural modifications
10. Selective protection against IgG binding to red cells treated with phthalocyanines and red light for virus inactivation
11. Virus inactivation in red cell concentrates by photosensitization with phthalocyanines: Protection of red cells but not of vesicular stomatitis virus with a water-soluble analogue of vitamin E
12. The effect of irradiance on virus sterilization and photodynamic damage in red blood cells sensitized by phthalocyanines
13. Importance of type I and type II mechanisms in the photodynamic inactivation of viruses in blood with aluminum phthalocyanine derivatives
14. Inactivation of viruses in red cell and platelet concentrates with aluminum phthalocyanine (AIPc) sulfonates
15. Inactivation of viruses in blood with aluminum phthalocyanine derivatives
16. Viral inactivation and reduction in cellular blood products
17. Merocyanine 540-sensitized photoinactivation of enveloped viruses in blood products: Site and mechanism of phototoxicity
18. Invited review: Advances in photochemical approaches for blood sterilization
19. Photodynamic inactivation of retrovirus by benzoporphyrin derivative: A feline leukemia virus model
20. Inactivation of viruses with photoactive compound
21. Hypericin as an inactivator of infectious viruses in blood components
22. Viral inactivation in RBC concentrates by inactine
23. In Vivo analysis of packed red blood cells treated with S-303 to inactivate pathogens
24. Photochemical inactivation of bacteria and HIV in buffy coat-derived platelet concentrates under conditions that preserve in vitro platelet function
25. Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light
26. Inactivation of human cytomegalovirus with psoralen and UVA in human platelet concentrates
27. Photochemical virus sterilization in platelet concentrates with psoralen derivatives
28. Viral inactivation in platelet concentrates
29. Inactivation of viruses in platelet suspensions that retain their in vitro characteristics: Comparison of psoralen-ultraviolet a and merocyanine 540-visible light methods
30. Determination of residual 4'-aminomethyl-4,5',8-trimethylpsoralen and mutagenicity testing following psoralen plus UVA treatment of platelet suspensions
31. Inactivation of free and cell-associated human immunodeficiency virus in platelet suspensions by aminomethyltrimethylpsoralen and ultraviolet light
32. Psoralen-mediated photodecontamination of platelet concentrates: Inactivation of cell-free and cell-associated forms of human immunodeficiency virus and assessment of platelet function in vivo
33. Quencher-enhanced specificity of psoralen-photosensitized virus inactivation in platelet concentrates
34. Virus sterilization in platelet concentrates with psoralen and ultraviolet a light in the presence of quenchers
35. Factors influencing virus inactivation and retention of platelet properties following treatment with aminomethyltrimethylpsoralen and UVA
36. Inactivation of viruses, bacteria, protozoa, and leukocytes in platelet concentrates
37. Photochemical inactivation of duck hepatitis B virus in human platelet concentrates: A model of surrogate human hepatitis B virus infectivity
38. Duck hepatitis B virus inactivation and 8-methoxypsoralen photoadduct formation in human platelet concentrates
39. Photochemical inactivation of cell-associated HIV in platelet concentrates
40. Photodynamic virus inactivation of thrombocyte concentrates by phenothiazine dyes
41. Effects of two viral inactivation methods on platelets: Laser-UV radiation and merocyanine 540-mediated photoinactivation
42. Advances in photochemical approaches for blood sterilization